{"id":"metformin-placebo-treatment-for-4-months","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-5","effect":"Metallic taste"},{"rate":"10-30","effect":"Vitamin B12 deficiency"},{"rate":"<0.1","effect":"Lactic acidosis (rare)"}]},"_chembl":{"chemblId":"CHEMBL1431","moleculeType":"Small molecule","molecularWeight":"129.17"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that primarily works by decreasing gluconeogenesis in the liver and enhancing peripheral glucose uptake and utilization. It may also improve insulin sensitivity and reduce intestinal glucose absorption. The drug does not stimulate insulin secretion, making it useful in various metabolic conditions.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in patients with type 2 diabetes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:37.069Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Prediabetes (investigational use in this trial context)"}]},"trialDetails":[{"nctId":"NCT07475546","phase":"PHASE3","title":"Combination Gerotherapeutic Interventions for Healthspan Improvement","status":"ACTIVE_NOT_RECRUITING","sponsor":"AgelessRx","startDate":"2025-07-23","conditions":"Healthspan Improvement, Aging, Longevity","enrollment":30},{"nctId":"NCT06611501","phase":"PHASE2","title":"Glycemic Regulation as Endometriosis Adjunct Treatment","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-05-22","conditions":"Pelvic Pain, Endometriosis","enrollment":14},{"nctId":"NCT01697566","phase":"PHASE3","title":"An Endometrial Cancer Chemoprevention Study of Metformin","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-05-30","conditions":"Gynecology","enrollment":29},{"nctId":"NCT05109169","phase":"PHASE2","title":"METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2023-01-25","conditions":"Cognitive Decline, Cognitive Impairment, Dementia","enrollment":600},{"nctId":"NCT02656017","phase":"PHASE2","title":"Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease","status":"COMPLETED","sponsor":"Kyongtae Ty Bae, M.D., Ph.D.","startDate":"2016-06-27","conditions":"Polycystic Kidney, Autosomal Dominant","enrollment":97},{"nctId":"NCT02491333","phase":"PHASE3","title":"The RCT of Acupuncture on PCOS Combined With IR","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2015-08","conditions":"Polycystic Ovary Syndrome, Insulin Resistance","enrollment":342},{"nctId":"NCT01775813","phase":"PHASE4","title":"The Health Influences of Puberty (HIP) Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2011-06","conditions":"Obesity, Insulin Resistance, Gonadal Dysfunction","enrollment":104},{"nctId":"NCT04706377","phase":"NA","title":"Vitamin B12 Supplementation in Diabetic Neuropathy","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2018-02-01","conditions":"Diabetes Mellitus, Diabetic Neuropathies, Diabetic Complication","enrollment":90},{"nctId":"NCT00151411","phase":"PHASE2","title":"Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2004-10","conditions":"Polycystic Ovary Syndrome","enrollment":114},{"nctId":"NCT01472432","phase":"PHASE4","title":"DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2011-05","conditions":"Chronic Foot Ulcers","enrollment":106},{"nctId":"NCT01464437","phase":"PHASE2","title":"AMG 151 Amgen Protocol Number 20100761","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-09","conditions":"Diabetes Mellitus","enrollment":236},{"nctId":"NCT00399360","phase":"NA","title":"Lifestyle Modification and Metformin Use in the Treatment of HIV","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2006-12","conditions":"HIV Infections, Metabolic Syndrome X","enrollment":50},{"nctId":"NCT00900146","phase":"PHASE2, PHASE3","title":"Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients","status":"TERMINATED","sponsor":"Novartis","startDate":"2009-04","conditions":"Diabetes Mellitus, Type 2","enrollment":556},{"nctId":"NCT00159575","phase":"PHASE4","title":"Metformin in Assisted Reproduction-MET-AR-study","status":"TERMINATED","sponsor":"Norwegian University of Science and Technology","startDate":"2005-03","conditions":"Polycystic Ovary Syndrome","enrollment":150},{"nctId":"NCT00679679","phase":"PHASE4","title":"Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Hospital Privado de Cordoba, Argentina","startDate":"2003-01","conditions":"Polycystic Ovary Syndrome","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Metformin / Placebo treatment for 4 months","genericName":"Metformin / Placebo treatment for 4 months","companyName":"Norwegian University of Science and Technology","companyId":"norwegian-university-of-science-and-technology","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in patients with type 2 diabetes. Used for Type 2 diabetes mellitus, Prediabetes (in research/prevention contexts).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}